Brand  (β version)

  The number of atoms exceeds 100,000.
  So, it can not be displayed here.

Select unit:

Select hetatm:   

close
information
centroid:
interaction residue:

Select chain:   Sequence  

Data format:   

Color scheme of protein:

Ligands
Code Name Style Show Link
ZN Zinc ion
MES 2-(N-morpholino)-ethanesulfonic acid
Non-standard Residues
Code Name Show
FAK N~6~-(trifluoroacetyl)-L-lysine
Glycosylation
Code Name Emphasize
Modification
Code Name Show
ACY Acetic acid
NH2 Amino group
Code : 4L3O   PDBj   RCSB PDB   PDBe
Header : HYDROLASE/HYDROLASE INHIBITOR
Title : Crystal Structure of SIRT2 in complex with the macrocyclic peptide S2iL5
Release Data : 2014-02-19
Compound :
mol_id molecule chains synonym
1 NAD-dependent protein deacetylase sirtuin-2 A,B,C,D Regulatory protein SIR2 homolog 2, SIR2-like protein 2
ec: 3.5.1.-
fragment: UNP residues 55-356
mol_id molecule chains
2 cyclic peptide S2iL5 E,F,G,H
Source :
mol_id organism_scientific organism_common expression_system
1 Homo sapiens  (taxid:9606) Human Escherichia coli  (taxid:562)
gene: SIRT2
expression_system_strain: BL21(DE3)
expression_system_vector_type: plasmid
expression_system_plasmid: pET-28a
mol_id organism_scientific
2
synthetic: yes
other_details: This sequence is chemically synthesized
Authors : Yamagata, K., Nishimasu, H., Ishitani, R., Nureki, O.
Keywords : macrocyclic peptide, structural change, HYDROLASE-HYDROLASE INHIBITOR complex
Exp. method : X-RAY DIFFRACTION ( 2.5180 Å )
Citation :

Structural Basis for Potent Inhibition of SIRT2 Deacetylase by a Macrocyclic Peptide Inducing Dynamic Structural Change

Yamagata, K.,Goto, Y.,Nishimasu, H.  et al.
(2013)  Structure  22 : 345 - 352

PubMed: 24389023
DOI: 10.1016/j.str.2013.12.001

Chain : A, B, C, D
UniProt : Q8IXJ6 (SIR2_HUMAN)
Reaction: EC: Evidence:
Physiological Direction:
H2O + N(6)-acetyl-L-lysyl-[protein] + NAD(+) = 2''-O-acetyl- ADP-D-ribose + L-lysyl-[protein] + nicotinamide 2.3.1.286 PROSITE-ProRule:PRU00236, PubMed:11483616, PubMed:11812793, PubMed:16648462, PubMed:18722353, PubMed:24177535, PubMed:24389023, PubMed:24940000, PubMed:25672491
-
H2O + N(6)-tetradecanoyl-L-lysyl-[protein] + NAD(+) = 2''-O- tetradecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide - PubMed:25704306, PubMed:32103017
left-to-right
H2O + N(6)-hexadecanoyl-L-lysyl-[protein] + NAD(+) = 2''-O- hexadecanoyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide - PubMed:29239724
left-to-right